NCT07633587
- Conditions
- Cardiomyopathies, Cardiovascular Diseases, Chemically-Induced Disorders, +13 more
- Locations
-
- Hopital Pitie-Salpetriere / CIC-2503 Paris, France
Clinical trial condition
Myotoxicity
Explore clinical trials studying Myotoxicity. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Myotoxicity trial results
Recruiting
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
NCT06707532
- Conditions
- Acute Kidney Injury, Arrhythmias, Cardiac, Butyrylcholinesterase deficiency, +33 more
- Locations
-
- 4th Military Clinical Hospital with Polyclinic Wroclaw, Lower Silesian Voivodeship, Poland
NCT06508177
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Muscular Diseases, +8 more
- Locations
-
- Samsun University Samsun, Turkey (Türkiye)
NCT05505890
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Muscular Diseases, +8 more
- Locations
-
- Samsun University Samsun, Turkey (Türkiye)
NCT04821245
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Local Anesthetic Complication, +11 more
- Locations
-
- Benaroya Research Institute Seattle, Washington, United States
NCT00199745
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Muscular Diseases, +8 more
- Locations
-
- Lipidklinikken, Rikshospitalet-Radiumhospitalet HF Oslo, Norway